{"transactions":[{"id":808794,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-04-14T22:18:58.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":13000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001914936-26-000009","document":"wk-form4_1776205136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000009/wk-form4_1776205136.xml","form_type":"4"}},{"id":808793,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-04-14T22:18:58.000Z","date":"2026-04-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5648,"price":9.06,"value":51170.88,"ownership":{"direct":true},"balance_after":177333,"source":{"system":"sec-edgar","filing":"0001914936-26-000009","document":"wk-form4_1776205136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000009/wk-form4_1776205136.xml","form_type":"4"}},{"id":808792,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-04-14T22:18:58.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":182981,"source":{"system":"sec-edgar","filing":"0001914936-26-000009","document":"wk-form4_1776205136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000009/wk-form4_1776205136.xml","form_type":"4"}},{"id":829280,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T20:59:22.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":18625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant of 74,500 RSUs vested in four approximately equal annual installments that began on March 21, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The original grant of 74,500 RSUs vested in four approximately equal annual installments that began on March 21, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18625},"source":{"system":"sec-edgar","filing":"0001914936-26-000007","document":"wk-form4_1774385959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000007/wk-form4_1774385959.xml","form_type":"4"}},{"id":829279,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-24T20:59:22.000Z","date":"2026-03-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":8091,"price":8.64,"value":69906.24,"ownership":{"direct":true},"balance_after":169981,"source":{"system":"sec-edgar","filing":"0001914936-26-000007","document":"wk-form4_1774385959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000007/wk-form4_1774385959.xml","form_type":"4"}},{"id":829278,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-24T20:59:22.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":18625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":178072,"source":{"system":"sec-edgar","filing":"0001914936-26-000007","document":"wk-form4_1774385959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000007/wk-form4_1774385959.xml","form_type":"4"}},{"id":837933,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":40500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837932,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":116000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":116000,"derivative":{"exercise_price":8.62,"expiration_date":"2036-03-13","underlying":"Class A Common Stock","underlying_shares":116000},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837931,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":104000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":104000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":104000},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837930,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:03:39.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":61000,"derivative":{"exercise_price":9.61,"expiration_date":"2035-03-14","underlying":"Class A Common Stock","underlying_shares":61000},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837929,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:03:39.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":54000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837928,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":5865,"price":8.62,"value":50556.3,"ownership":{"direct":true},"balance_after":159447,"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837927,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":165312,"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":896810,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T23:30:05.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":false,"shares":20153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":40304,"derivative":{"underlying":"Class A Common Stock","underlying_shares":20153},"source":{"system":"sec-edgar","filing":"0001914936-26-000002","document":"wk-form4_1771457403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000002/wk-form4_1771457403.xml","form_type":"4"}},{"id":896809,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-02-18T23:30:05.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9429,"price":8.27,"value":77977.83,"ownership":{"direct":true},"balance_after":151812,"source":{"system":"sec-edgar","filing":"0001914936-26-000002","document":"wk-form4_1771457403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000002/wk-form4_1771457403.xml","form_type":"4"}},{"id":896808,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-02-18T23:30:05.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":true,"shares":20153,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":161241,"source":{"system":"sec-edgar","filing":"0001914936-26-000002","document":"wk-form4_1771457403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000002/wk-form4_1771457403.xml","form_type":"4"}},{"id":1171793,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2025-04-15T21:50:38.000Z","date":"2025-04-11","kind":"sale","planned":true,"acquired":false,"shares":3875,"price":7.57,"value":29333.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on April 10, 2025 pursuant to a standing 10b5-1 instruction adopted on April 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $7.145 to $7.890, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141088,"source":{"system":"sec-edgar","filing":"0001578563-25-000219","document":"wk-form4_1744753832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000219/wk-form4_1744753832.xml","form_type":"4"}},{"id":1173269,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2025-04-11T21:31:11.000Z","date":"2025-04-10","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":26000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001578563-25-000211","document":"wk-form4_1744407063.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000211/wk-form4_1744407063.xml","form_type":"4"}},{"id":1173268,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2025-04-11T21:31:11.000Z","date":"2025-04-10","kind":"exercise","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144963,"source":{"system":"sec-edgar","filing":"0001578563-25-000211","document":"wk-form4_1744407063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000211/wk-form4_1744407063.xml","form_type":"4"}},{"id":1192238,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2025-03-25T21:37:03.000Z","date":"2025-03-24","kind":"sale","planned":true,"acquired":false,"shares":5479,"price":9.79,"value":53639.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2025 pursuant to a standing 10b5-1 instruction adopted on April 4, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $9.70 to $9.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":131963,"source":{"system":"sec-edgar","filing":"0001578563-25-000191","document":"wk-form4_1742938616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000191/wk-form4_1742938616.xml","form_type":"4"}},{"id":1194626,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2025-03-21T21:24:27.000Z","date":"2025-03-21","kind":"exercise","planned":false,"acquired":false,"shares":18625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023."}],"balance_after":18625,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18625},"source":{"system":"sec-edgar","filing":"0001578563-25-000187","document":"wk-form4_1742592261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000187/wk-form4_1742592261.xml","form_type":"4"}},{"id":1194625,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2025-03-21T21:24:27.000Z","date":"2025-03-21","kind":"exercise","planned":false,"acquired":true,"shares":18625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":137442,"source":{"system":"sec-edgar","filing":"0001578563-25-000187","document":"wk-form4_1742592261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000187/wk-form4_1742592261.xml","form_type":"4"}},{"id":1255750,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2025-02-21T00:01:25.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":6498,"price":10.19,"value":66214.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on February 15, 2025 pursuant to a standing 10b5-1 instruction adopted on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $9.74 to $10.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":118817,"source":{"system":"sec-edgar","filing":"0001578563-25-000121","document":"wk-form4_1740096077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000121/wk-form4_1740096077.xml","form_type":"4"}},{"id":1263785,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T23:00:56.000Z","date":"2025-02-15","kind":"exercise","planned":false,"acquired":false,"shares":20153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024,  in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024,  in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":60457,"derivative":{"underlying":"Class A Common Stock","underlying_shares":20153},"source":{"system":"sec-edgar","filing":"0001578563-25-000074","document":"wk-form4_1739919650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000074/wk-form4_1739919650.xml","form_type":"4"}},{"id":1263784,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2025-02-18T23:00:56.000Z","date":"2025-02-15","kind":"exercise","planned":false,"acquired":true,"shares":20153,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":125315,"source":{"system":"sec-edgar","filing":"0001578563-25-000074","document":"wk-form4_1739919650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000074/wk-form4_1739919650.xml","form_type":"4"}},{"id":1321653,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-12-26T21:55:55.000Z","date":"2024-12-23","kind":"sale","planned":true,"acquired":false,"shares":10733,"price":10.53,"value":113018.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on December 20, 2024 pursuant to a standing 10b5-1 instruction adopted on June 20, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $10.41 to $10.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105162,"source":{"system":"sec-edgar","filing":"0001578563-24-000517","document":"wk-form4_1735250149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000517/wk-form4_1735250149.xml","form_type":"4"}},{"id":1322852,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-12-23T22:28:52.000Z","date":"2024-12-20","kind":"exercise","planned":false,"acquired":false,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested 50% on the twelve-month anniversary of the date of grant, and the remaining 50% vested on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested 50% on the twelve-month anniversary of the date of grant, and the remaining 50% vested on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001578563-24-000508","document":"wk-form4_1734992926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000508/wk-form4_1734992926.xml","form_type":"4"}},{"id":1322851,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-12-23T22:28:52.000Z","date":"2024-12-20","kind":"exercise","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":115895,"source":{"system":"sec-edgar","filing":"0001578563-24-000508","document":"wk-form4_1734992926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000508/wk-form4_1734992926.xml","form_type":"4"}},{"id":1469509,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-06-25T20:59:16.000Z","date":"2024-06-21","kind":"sale","planned":true,"acquired":false,"shares":9219,"price":5.57,"value":51349.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on June 20, 2024 pursuant to a standing 10b5-1 instruction adopted on June 20, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $5.515 to $5.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":84895,"source":{"system":"sec-edgar","filing":"0001578563-24-000326","document":"wk-form4_1719349150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000326/wk-form4_1719349150.xml","form_type":"4"}},{"id":1470677,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-06-25T00:46:26.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest 50% on the twelve-month anniversary of the date of grant, and the remaining 50% shall vest on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest 50% on the twelve-month anniversary of the date of grant, and the remaining 50% shall vest on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":31000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001578563-24-000318","document":"wk-form4_1719276379.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000318/wk-form4_1719276379.xml","form_type":"4"}},{"id":1470676,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-06-25T00:46:26.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":94114,"source":{"system":"sec-edgar","filing":"0001578563-24-000318","document":"wk-form4_1719276379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000318/wk-form4_1719276379.xml","form_type":"4"}},{"id":1472031,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:27:26.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":13753,"price":5.84,"value":80317.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on June 15, 2024 pursuant to a standing 10b5-1 instruction adopted on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $5.525 to $6.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":63114,"source":{"system":"sec-edgar","filing":"0001578563-24-000312","document":"wk-form4_1719001639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000312/wk-form4_1719001639.xml","form_type":"4"}},{"id":1475319,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-06-18T21:42:30.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":false,"shares":42202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 15, 2024."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":42202},"source":{"system":"sec-edgar","filing":"0001578563-24-000302","document":"wk-form4_1718746944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000302/wk-form4_1718746944.xml","form_type":"4"}},{"id":1475318,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-06-18T21:42:30.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":true,"shares":42202,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":76867,"source":{"system":"sec-edgar","filing":"0001578563-24-000302","document":"wk-form4_1718746944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000302/wk-form4_1718746944.xml","form_type":"4"}},{"id":1541874,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-04-15T22:03:06.000Z","date":"2024-04-11","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":4.75,"value":19000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on April 10, 2024 pursuant to a standing 10b5-1 instruction adopted on April 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price calculated by the broker executing the\nsales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $4.53 to $4.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34665,"source":{"system":"sec-edgar","filing":"0001578563-24-000203","document":"wk-form4_1713218576.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000203/wk-form4_1713218576.xml","form_type":"4"}},{"id":1542549,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-04-12T20:54:11.000Z","date":"2024-04-10","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":39000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001578563-24-000193","document":"wk-form4_1712955243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000193/wk-form4_1712955243.xml","form_type":"4"}},{"id":1542548,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-04-12T20:54:11.000Z","date":"2024-04-10","kind":"exercise","planned":false,"acquired":true,"shares":13000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."}],"balance_after":38665,"source":{"system":"sec-edgar","filing":"0001578563-24-000193","document":"wk-form4_1712955243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000193/wk-form4_1712955243.xml","form_type":"4"}},{"id":1561878,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-03-25T21:36:27.000Z","date":"2024-03-21","kind":"exercise","planned":false,"acquired":false,"shares":18625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023."}],"balance_after":37250,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18625},"source":{"system":"sec-edgar","filing":"0001578563-24-000182","document":"wk-form4_1711402578.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000182/wk-form4_1711402578.xml","form_type":"4"}},{"id":1561877,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-03-25T21:36:27.000Z","date":"2024-03-22","kind":"sale","planned":false,"acquired":false,"shares":5541,"price":5.3876,"value":29852.6916,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2024 pursuant to a standing 10b5-1 instruction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.36 to $5.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25665,"source":{"system":"sec-edgar","filing":"0001578563-24-000182","document":"wk-form4_1711402578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000182/wk-form4_1711402578.xml","form_type":"4"}},{"id":1561876,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2024-03-25T21:36:27.000Z","date":"2024-03-21","kind":"exercise","planned":false,"acquired":true,"shares":18625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."}],"balance_after":31206,"source":{"system":"sec-edgar","filing":"0001578563-24-000182","document":"wk-form4_1711402578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000182/wk-form4_1711402578.xml","form_type":"4"}},{"id":1563358,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T21:22:04.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":181980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":181980,"derivative":{"exercise_price":5.45,"expiration_date":"2034-03-15","underlying":"Class A Common Stock","underlying_shares":181980},"source":{"system":"sec-edgar","filing":"0001578563-24-000180","document":"wk-form4_1711142512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000180/wk-form4_1711142512.xml","form_type":"4"}},{"id":1563357,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-03-22T21:22:04.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":42202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest on June 15, 2024,  subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest on June 15, 2024,  subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":42202,"derivative":{"underlying":"Class A Common Stock","underlying_shares":42202},"source":{"system":"sec-edgar","filing":"0001578563-24-000180","document":"wk-form4_1711142512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000180/wk-form4_1711142512.xml","form_type":"4"}},{"id":1563356,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-03-22T21:22:04.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":80610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":80610,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80610},"source":{"system":"sec-edgar","filing":"0001578563-24-000180","document":"wk-form4_1711142512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000180/wk-form4_1711142512.xml","form_type":"4"}},{"id":1846516,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-06-22T21:08:12.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest 50% on the twelve-month anniversary of the date of grant, and the remaining 50% shall vest on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest 50% on the twelve-month anniversary of the date of grant, and the remaining 50% shall vest on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":62000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001578563-23-000055","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000055/primary_doc.xml","form_type":"4"}},{"id":1920975,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-13T01:14:53.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":135800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":135800,"derivative":{"exercise_price":1.16,"expiration_date":"2033-04-10","underlying":"Class A Common Stock","underlying_shares":135800},"source":{"system":"sec-edgar","filing":"0001578563-23-000021","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000021/primary_doc.xml","form_type":"4"}},{"id":1920974,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-04-13T01:14:53.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":52000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001578563-23-000021","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000021/primary_doc.xml","form_type":"4"}},{"id":1937889,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2023-03-27T23:27:14.000Z","date":"2023-03-24","kind":"sale","planned":false,"acquired":false,"shares":6044,"price":1.27,"value":7675.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2023 pursuant to a standing Rule 10b5-1 instruction provision in the award agreement, dated March 21, 2022."}],"balance_after":12581,"source":{"system":"sec-edgar","filing":"0000899243-23-009758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924323009758/doc4.xml","form_type":"4"}},{"id":1940161,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-03-23T20:15:33.000Z","date":"2023-03-21","kind":"exercise","planned":false,"acquired":false,"shares":18625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023."}],"balance_after":55875,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18625},"source":{"system":"sec-edgar","filing":"0000899243-23-009522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924323009522/doc4.xml","form_type":"4"}},{"id":1940160,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2023-03-23T20:15:33.000Z","date":"2023-03-21","kind":"exercise","planned":false,"acquired":true,"shares":18625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."}],"balance_after":18625,"source":{"system":"sec-edgar","filing":"0000899243-23-009522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924323009522/doc4.xml","form_type":"4"}},{"id":2304458,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-06T01:06:40.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":223200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 21, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":223200,"derivative":{"exercise_price":13.29,"expiration_date":"2032-04-03","underlying":"Class A Common Stock","underlying_shares":223200},"source":{"system":"sec-edgar","filing":"0000899243-22-013948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322013948/doc4.xml","form_type":"4"}},{"id":2304457,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2022-04-06T01:06:40.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":74500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 21, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 21, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":74500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":74500},"source":{"system":"sec-edgar","filing":"0000899243-22-013948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322013948/doc4.xml","form_type":"4"}}]}